These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15266608)

  • 1. Germline mosaicism resulting in the transmission of severe hemophilia B from a grandfather with a mild deficiency.
    Cutler JA; Mitchell MJ; Smith MP; Savidge GF
    Am J Med Genet A; 2004 Aug; 129A(1):13-5. PubMed ID: 15266608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B.
    Kim HJ; Lee KO; Yoo KY; Kim SH; Kim HJ
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):866-8. PubMed ID: 25402191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic mosaicism and female-to-female transmission in a kindred with hemophilia B (factor IX deficiency).
    Taylor SA; Deugau KV; Lillicrap DP
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):39-42. PubMed ID: 1986380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mosaicism in a female who seemed to be a carrier by sequence analysis.
    Sommer SS; Knöll A; Greenberg CR; Ketterling RP
    Hum Mol Genet; 1995 Nov; 4(11):2181-2. PubMed ID: 8589701
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurence of haemophilia A and B in a Chinese family with mosaicism of the F9 gene mutation in the HB index's maternal grandfather.
    Lu Y; Xie B; Ding Q; Dai J; Xi X; Wang M; Wang H; Wang X
    Thromb Haemost; 2010 May; 103(5):1106-8. PubMed ID: 20174753
    [No Abstract]   [Full Text] [Related]  

  • 7. Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B.
    Wang X; Tang N; Shen N; Zhu Y; Lu Y; Gao L
    Hematology; 2020 Dec; 25(1):484-488. PubMed ID: 33295842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic mosaicism and compound heterozygosity in female hemophilia B.
    Costa JM; Vidaud D; Laurendeau I; Vidaud M; Fressinaud E; Moisan JP; David A; Meyer D; Lavergne JM
    Blood; 2000 Aug; 96(4):1585-7. PubMed ID: 10942410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemophilia B in a female.
    Shetty S; Ghosh K; Mohanty D
    Acta Haematol; 2001; 106(3):115-7. PubMed ID: 11713376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: non-homologous recombination associated with a shortened transcript from whole blood.
    Hsu TC; Nakaya SM; Thompson AR
    Thromb Haemost; 2007 Feb; 97(2):176-80. PubMed ID: 17264943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
    Driscoll MC; Bouhassira E; Aledort LM
    Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia B: molecular pathogenesis and mutation analysis.
    Goodeve AC
    J Thromb Haemost; 2015 Jul; 13(7):1184-95. PubMed ID: 25851415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors.
    Shu M; Malcolmson C; Bosch A; Markovic T; Wakefield C; Bouskill V; Carcao M
    Haemophilia; 2024 Jul; 30(4):1003-1009. PubMed ID: 38924261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophilia B carrier detection by factor IX:C analysis; no impact of the type of mutation or severity of disorder.
    Knobe KE; Ljung RC
    Haemophilia; 1999 Jul; 5(4):238-42. PubMed ID: 10469176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of carrier status of hemophilia B using DNA markers.
    Ishak R; Zakaria Z
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):629-30. PubMed ID: 9561621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of correlation between X chromosome inactivation pattern and plasma concentration of factor VIII and factor IX in carriers of haemophilia A and B.
    Orstavik KH; Scheibel E; Ingerslev J; Schwartz M
    Thromb Haemost; 2000 Mar; 83(3):433-7. PubMed ID: 10744150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A deletion mutation causes hemophilia B in Lhasa Apso dogs.
    Mauser AE; Whitlark J; Whitney KM; Lothrop CD
    Blood; 1996 Nov; 88(9):3451-5. PubMed ID: 8896410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An intragenic deletion of the factor IX gene in a family with hemophilia B.
    Chen SH; Yoshitake S; Chance PF; Bray GL; Thompson AR; Scott CR; Kurachi K
    J Clin Invest; 1985 Dec; 76(6):2161-4. PubMed ID: 3001143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.